Zee Media Bureau
New Delhi: A drug known as metformin, commonly used in the front-line treatment for Type-2 diabetes is capable to beat breast cancer, says a new study.
For the study, the researchers examined clinical outcomes for 1,215 patients who were diagnosed and underwent surgical treatment for breast cancer between 1997 and 2013.
Ninety-seven patients examined reported using metformin before their diagnosis, and 97 reported use of the drug after diagnosis.
Results of the study showed that patients who used metformin before being diagnosed with breast cancer were more than twice as likely to die than patients who never used the drug.
On the other hand, patients who began using metformin after their cancer diagnosis were almost 50 percent more likely to survive than non-users.
(With IANS inputs)